Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Synovus Financial Corp. (NYSE:SNV), Sodastream International Ltd (NASDAQ:SODA), Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG).
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) ended its recent business day with the tumbled of -8.00% and closed at the price of $2.30 after opening at $2.61. The stock traded during its last trading session with the total volume of 7.70 million shares, as compared to its average volume of 2.67 million shares. Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products.
Has CHTP Found The Bottom And Ready To Gain Momentum? Find Out Here
Synovus Financial Corp. (NYSE:SNV) remained among the day bearish -1.40% and traded with volume of 10.87 million shares in the last session, as compared to average volume of 6.17 million shares. In comparison with 52 week range of $2.41 - $3.62, it faced lowest price of $3.50 during the last trading session whereas its day highest price was $3.57. The company’s total market capitalization is $3.41 billion, along with 972.26 million shares outstanding. Synovus financial corp., a financial services and bank holdin company, provides integrated financial services.
Why Should Investors Buy SNV After the Recent Fall? Just Go Here and Find Out
Sodastream International Ltd (NASDAQ:SODA) showed 10.84 million shares in volume during the last trading session, while the average trading volume remained 991,615.00 shares. The stock kicked off its trading session at $41.45 and closed at $36.94 after dropped -25.96%. SodaStream International Ltd. engages in the development, manufacture, and sale of home beverage carbonation systems that enable consumers to transform ordinary tap water instantly into carbonated soft drinks and sparkling water.
Will SODA Get Buyers Even After The Recent Rally? Find Out Here
Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) stock traded during its last trading session with the total traded volume of 7.25 million shares versus its average volume of 283,451.00 shares. The company opened its trade at the price of $4.05 and its closing price was $3.77 after gained 18.18% for the day. Rosetta Genomics Ltd. develops and commercializes a range of microRNA-based diagnostic tools. MicroRNAs are a group of genes that are produced using instructions encoded in DNA.
For How Long ROSG will fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)